Effects of convulsant barbiturates on endogenous acetylcholine release and sodium-dependent high affinity choline uptake.
D000109:Acetylcholine / Q000378:metabolism*; D000818:Animals; D001463:Barbiturates / Q000031:analogs & derivatives / Q000494:pharmacology*; D002794:Choline / Q000378:metabolism*; D006624:Hippocampus / Q000187:drug effects; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D011188:Potassium / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D014701:Veratridine / Q000494:pharmacology
D001463:Barbiturates; C024321:5-(2-cyclohexylidene-ethyl)-5-ethylbarbiturate; D014701:Veratridine; D012964:Sodium; D002794:Choline; D000109:Acetylcholine; D011188:Potassium